Cholera toxin B subunit pentamer reassembled from Escherichia coli inclusion bodies for use in vaccination.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Vaccine

• Publication date

  2016-03-04

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.vaccine.2016.01.034PMID 26828455
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cholera toxin B subunit-five-stranded α-helical coiled-coil fusion protein: "five-to-five" molecular chimera displays robust physicochemical stability.

  2014cited by this paper
• Merozoite surface protein-1 of Plasmodium yoelii fused via an oligosaccharide moiety of cholera toxin B subunit glycoprotein expressed in yeast induced protective immunity against lethal malaria infection in mice.

  2012cited by this paper
• Physicochemically stable cholera toxin B subunit pentamer created by peripheral molecular constraints imposed by de novo-introduced intersubunit disulfide crosslinks.

  2012cited by this paper
• Tricomponent Immunopotentiating System as a Novel Molecular Design Strategy for Malaria Vaccine Development

  2011cited by this paper
• Vaccination with Dukoral® against travelers’ diarrhea (ETEC) and cholera

  2008cited by this paper
• Current status of technical protein refolding.

  2007cited by this paper
• Heteropentameric Cholera Toxin B Subunit Chimeric Molecules Genetically Fused to a Vaccine Antigen Induce Systemic and Mucosal Immune Responses: a Potential New Strategy To Target Recombinant Vaccine Antigens to Mucosal Immune Systems

  2005cited by this paper
• Expression and characterization of cholera toxin B-pneumococcal surface adhesin A fusion protein in Escherichia coli: ability of CTB-PsaA to induce humoral immune response in mice.

  2004cited by this paper
• In vitro protein refolding by chromatographic procedures.

  2004cited by this paper
• Practical considerations in refolding proteins from inclusion bodies.

  2003cited by this paper
• The likelihood of aggregation during protein renaturation can be assessed using the second virial coefficient

  2003cited by this paper
• Synthesis of cholera toxin B subunit gene: cloning and expression of a functional 6XHis-tagged protein in Escherichia coli.

  2002cited by this paper
• A Kinetic Model of Intermediate Formation during Assembly of Cholera Toxin B-subunit Pentamers*

  2002cited by this paper
• Inhibition of aggregation side reactions during in vitro protein folding.

  1999cited by this paper
• Advances in refolding of proteins produced in E. coli.

  1998cited by this paper
• Removal of endotoxin from recombinant protein preparations.

  1997cited by this paper
• Fusions to the cholera toxin B subunit: influence on pentamerization and GM1 binding.

  1997cited by this paper
• Effect of Inclusion Body Contaminants on the Oxidative Renaturation of Hen Egg White Lysozyme

  1997cited by this paper
• In vitro folding of inclusion body proteins

  1996cited by this paper
• Recombinant cholera toxin B subunit in Escherichia coli: high-level secretion, purification, and characterization.

  1994cited by this paper
• Large-Scale Production of Vibrio cholerae Toxin B Subunit for Use in Oral Vaccines

  1993cited by this paper
• Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers.

  1992cited by this paper
• Expression in Escherichia coli of two mutated genes encoding the cholera toxin B subunit.

  1990cited by this paper
• Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development.

  1989cited by this paper
• Genetic fusion of a non‐toxic heat‐stable enterotoxin‐related decapeptide antigen to cholera toxin B‐subunit

  1988cited by this paper
• Coordinated assembly of multisubunit proteins: oligomerization of bacterial enterotoxins in vivo and in vitro.

  1988cited by this paper
• Conformation of protein secreted across bacterial outer membranes: a study of enterotoxin translocation from Vibrio cholerae.

  1987cited by this paper

• Cloning, Expression and Purification of the Beta Subunit of Cholera Toxin Using Escherichia coli as an Expression Host and pET-24a(+) as a Cloning Vector

  2026influential citation
• SELEX-based aptamer production: A key step in cholera detection

  2025cites this paper
• Evaluation of Cholera Toxin B Subunit as a Novel Carrier Protein for Polysaccharide Conjugate Vaccines

  2025cites this paper
• B subunit of the type 2 Shiga toxin e variant (Stx2e) bundled by a five-stranded α-helical coiled coil protects piglets from porcine edema disease.

  2025cites this paper
• Harnessing Pentameric Scaffold of Cholera Toxin B (CTB) for Design of Subvirion Recombinant Dengue Virus Vaccine

  2024cites this paper
• Shiga toxin type 2 B subunit protects mice against toxin challenge when leashed and bundled by a stable pentameric coiled-coil molecule.

  2024cites this paper
• Immunological effects of recombinant Lactobacillus casei expressing pilin MshB fused with cholera toxin B subunit adjuvant as an oral vaccine against Aeromonas veronii infection in crucian carp.

  2023cites this paper
• Design and Synthesis of Glycosylated Cholera Toxin B Subunit as a Tracer of Glycoprotein Trafficking in Organelles of Living Cells.

  2022cites this paper
• B subunit of cholera toxin fused with VP7 from GCRV (grass carp reovirus) was expressed in E. coli and folds into an active protein.

  2020cites this paper
• Production of Chicken Egg Yolk Antibody (IgY) Against Recombinant Cholera Toxin B Subunit and Evaluation of Its Prophylaxis Potency in Mice.

  2018cites this paper
• Designing an efficient multi-epitope oral vaccine against Helicobacter pylori using immunoinformatics and structural vaccinology approaches.

  2017cites this paper
• Enhanced soluble production of cholera toxin B subunit in Escherichia coli by co-expression of SKP chaperones.

  2017cites this paper